Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A2Areceptor knockout mice with microarray profiling
- 1 May 2009
- journal article
- research article
- Published by American Physiological Society in Physiological Genomics
- Vol. 37 (3), 199-210
- https://doi.org/10.1152/physiolgenomics.90353.2008
Abstract
Caffeine is the most widely consumed psychoactive substance and has complex pharmacological actions in brain. In this study, we employed a novel drug target validation strategy to uncover the multiple molecular targets of caffeine using combined A2Areceptor (A2AR) knockouts (KO) and microarray profiling. Caffeine (10 mg/kg) elicited a distinct profile of striatal gene expression in WT mice compared with that by A2AR gene deletion or by administering caffeine into A2AR KO mice. Thus, A2ARs are required but not sufficient to elicit the striatal gene expression by caffeine (10 mg/kg). Caffeine (50 mg/kg) induced complex expression patterns with three distinct sets of striatal genes: 1) one subset overlapped with those elicited by genetic deletion of A2ARs; 2) the second subset elicited by caffeine in WT as well as A2AR KO mice; and 3) the third subset elicited by caffeine only in A2AR KO mice. Furthermore, striatal gene sets elicited by the phosphodiesterase (PDE) inhibitor rolipram and the GABAAreceptor antagonist bicucullin, overlapped with the distinct subsets of striatal genes elicited by caffeine (50 mg/kg) administered to A2AR KO mice. Finally, Gene Set Enrichment Analysis reveals that adipocyte differentiation/insulin signaling is highly enriched in the striatal gene sets elicited by both low and high doses of caffeine. The identification of these distinct striatal gene populations and their corresponding multiple molecular targets, including A2AR, non-A2AR (possibly A1Rs and pathways associated with PDE and GABAAR) and their interactions, and the cellular pathways affected by low and high doses of caffeine, provides molecular insights into the acute pharmacological effects of caffeine in the brain.Keywords
This publication has 57 references indexed in Scilit:
- Mice heterozygous for both A1 and A2A adenosine receptor genes show similarities to mice given long-term caffeineJournal of Applied Physiology, 2009
- Caffeine analogs: biomedical impactCellular and Molecular Life Sciences, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Binding of the prototypical adenosine A2A receptor agonist CGS 21680 to the cerebral cortex of adenosine A1 and A2A receptor knockout miceBritish Journal of Pharmacology, 2004
- Regulation of gene expression and cocaine reward by CREB and ΔFosBNature Neuroscience, 2003
- Multiple Hypothesis Testing in Microarray ExperimentsStatistical Science, 2003
- Coffee consumption and risk of type 2 diabetes mellitusThe Lancet, 2002
- Drug target validation and identification of secondary drug target effects using DNA microarraysNature Medicine, 1998
- Caffeine and theophylline analogues: Correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitorsLife Sciences, 1988
- Purinergic inhibition of diazepam binding to rat brain (in vitro)Life Sciences, 1979